ResearcherWenzhou Medical UniversityNo recent work listed
Chaohao Huang
Matched on ORCID iD 0000-0001-7292-7866; OpenAlex author ID A5016899400. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper
Papers 6
- Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database. Last author DOI 10.1155/2021/5573628↗
- Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. Co-author DOI 10.1155/2018/2360427↗
- Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway. Co-author DOI 10.1016/j.bbrc.2017.04.133↗
- Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic can… Co-author DOI 10.1111/cas.13347↗
- Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corri… Co-author DOI 10.2147/ott.s140829↗
- Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells. Co-author DOI 10.2147/ott.s122653↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dinglai Yu · 6 shared papers, 2016–2021 · strength 0.48
- Paper Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cance… DOI 10.1155/2021/5573628↗
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Bicheng Chen · 5 shared papers, 2016–2018 · strength 0.34
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Paper Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK sig… DOI 10.2147/ott.s140829↗
- Yukai Xiang · 4 shared papers, 2017–2021 · strength 0.34
- Paper Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cance… DOI 10.1155/2021/5573628↗
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Shengjie Dai · 3 shared papers, 2016–2021 · strength 0.27
- Paper Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cance… DOI 10.1155/2021/5573628↗
- Paper Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK sig… DOI 10.2147/ott.s140829↗
- Paper Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in… DOI 10.2147/ott.s122653↗
- Xince Huang · 3 shared papers, 2016–2017 · strength 0.21
- Paper Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling … DOI 10.1016/j.bbrc.2017.04.133↗
- Paper Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK sig… DOI 10.2147/ott.s140829↗
- Paper Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in… DOI 10.2147/ott.s122653↗
- Mengtao Zhou · 3 shared papers, 2016–2018 · strength 0.20
- Paper Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway. DOI 10.1155/2018/2360427↗
- Paper Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activa… DOI 10.1111/cas.13347↗
- Paper Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in… DOI 10.2147/ott.s122653↗
- Hongwei Sun · 2 shared papers, 2017–2021 · strength 0.20
- Paper Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cance… DOI 10.1155/2021/5573628↗
- Paper Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activa… DOI 10.1111/cas.13347↗
- Tingting Ye · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK sig… DOI 10.2147/ott.s140829↗
- Paper Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in… DOI 10.2147/ott.s122653↗
- Bi Lin · 1 shared paper, 2021 · strength 0.13
- Jie Zhang · 1 shared paper, 2018 · strength 0.07
- Keqing Shi · 1 shared paper, 2018 · strength 0.07
- Jie Zhang · 1 shared paper, 2017 · strength 0.07
- Mengtao Zhou · 1 shared paper, 2017 · strength 0.07
- Zhengde Wen · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.